Caladrius Biosciences, Inc. (CLBS) Social Stream



Caladrius Biosciences, Inc. (CLBS): $0.76

-0.02 (-1.95%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add CLBS to Watchlist
Sign Up

Industry: Biotech


Ranked

of 461

in industry

Caladrius Biosciences Inc (CLBS) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering Caladrius Biosciences Inc.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
3 $10 $8 $9 $0.865 940.46%
2 $10 $8 $9 $0.865 940.46%

The Trend in the Analyst Price Target


CLBS's average price target has moved down $0.62 over the prior 18 months.

Over the past 18 months, CLBS's average upside potential has been 512.94%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-11-05 3 10.0 8 9.00 1.13 696.46%
2021-11-05 2 10.0 8 9.00 1.13 696.46%
2020-05-21 3 18.5 6 9.62 NA NA%

CLBS Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.67 2 0 1 0 0 3

The Trend in the Broker Recommendations


CLBS's average broker recommendation rating improved by 0.5 over the prior 15 months.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • CLBS has a greater upside potential (average analyst target price relative to current price) than 198.9% of all US stocks.
  • In the context of Healthcare stocks, Caladrius Biosciences Inc's number of analysts covering the stock is higher than 12.93% of them.
  • To contextualize these metrics, consider that out of Healthcare stocks, Caladrius Biosciences Inc's average analyst price target is greater than 18.04% of them.
  • To contextualize these metrics, consider that out of Healthcare stocks, Caladrius Biosciences Inc's variance in analysts' estimates is lower than 58.44% of them.

In terms of price targets and recommendations offered by analysts, the stocks in the Healthcare industry with the ratings most similar to Caladrius Biosciences Inc are IMAC, PIII and BXRX.

Is CLBS a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.8128 seconds.